Anti-drug antibodies of IL-17 inhibitors for psoriasis: a systematic review
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2022.2114288
Abstract: Abstract Biologics may elicit the production of anti-drug antibodies (ADAs), the clinical significance of which is not fully understood. ADA development in psoriasis patients on IL-17 inhibitors was evaluated by incidence, impact on efficacy, and… read more here.
Keywords: ixekizumab brodalumab; drug antibodies; anti drug; antibodies inhibitors ... See more keywords
Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.
Sign Up to like & getrecommendations! Published in 2023 at "Drugs of today"
DOI: 10.1358/dot.2023.59.3.3419557
Abstract: In recent years, the role of interleukin-17 (IL-17) in orchestrating and manipulating proinflammatory immune responses has received special attention. It has become apparent from murine studies and clinical trials that due to its inhibitory effect… read more here.
Keywords: psoriasis psoriatic; bimekizumab brodalumab; psoriatic arthritis; ixekizumab bimekizumab ... See more keywords